Position in RVMD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$110,237,347
+$25,794,729 QoQ
Shares Held
1,133,546
+6.9% QoQ
Ownership
0.533%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 98.98160286393318.ToString("F0")%
Shared 0.ToString("F0")%
None 1.0183971360668203.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $7,056,412,222 across 165 Biotechnology names. RVMD ranks #12 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,722,071 | $2,103,180,930 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,051,948 | $469,342,063 | |
| 3 | INSM |
INSMED Inc
|
2,617,251 | $427,972,880 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,958,940 | $370,337,604 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,132 | $246,102,477 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,438,925 | $181,114,568 | |
| 7 | ARGX |
Argenx SE
|
233,493 | $170,508,261 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
470,390 | $155,637,935 |
All Filings in RVMD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $110,237,347 | 1,133,546 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $84,442,618 | 1,060,171 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $44,434,582 | 951,490 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,262,985 | 251,780 | Shares | Defined | 2025-08-12 | |
| 2020-09-30 | $12,610,476 | 362,370 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $11,051,709 | 350,070 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $7,668,500 | 350,000 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||